SYRACUSE — ClearPath Diagnostics has launched a new women’s health molecular assay for the detection of Group B Streptococcus (GBS) from Meridian Bioscience, Inc. The new assay, named illumigene GBS, is the next generation of technology for GBS testing, ClearPath says. Sensitivity on the new assay approaches 99 percent versus a range of 65 percent […]
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
OSWEGO, N.Y. — Oswego Health says it had the system’s first robotically assisted surgery using…
JOHNSON CITY, N.Y. — Tioga State Bank (TSB) will open a new branch in Johnson…
UTICA, N.Y. — A report by the Oneida County Childcare Taskforce made a number of…
ITHACA, N.Y. — Cayuga Health System (CHS), based in Ithaca, and Cancer Resource Center of…
DeWITT, N.Y. — MACNY, the Manufacturers Association will use a $6 million federal grant to…
SYRACUSE, N.Y. — The Syracuse Housing Authority (SHA) and the City of Syracuse will use…